Don’t it always seem to go, That you don’t know what you’ve got ’til it’s gone. They paved paradise, And put up a parking lot.” — from “Big Yellow Taxi” by Joni Mitchell An opinion/policy piece appeared two days ago in the New York Times entitled “Why Medical School Should Be Free.” Hey, why not? […]
Shareholders of Orthovita Inc. (NSDQ: VITA), a Malvern, Pa.-based orthopedic biologics maker, are suing over a proposed $316 million merger by Stryker Corp. (NYSE:SYK ) that represents a hefty percent premium on VITA stock price. The stockholders, led by Andrew Thorn, accused the two companies and Orthovita’s board of breaching its fiduciary duty in agreeing […]
In a webinar on April 16 at 1pm ET, Aneesh Chopra will moderate a discussion with executives from DocuSign, Velatura, and behavioral health providers on eConsent, health information exchange and compliance with the CMS Final Rule on interoperability.
GlaxoSmithKline‘s (NYSE:GSK) HIV treatment combivir will soon face its first competition from a generic drug. Teva Pharmaceutical Industries (NASDAQ:TEVA) has received U.S. Food and Drug Administration approval on its application to market a generic version of combivir. Combivir is a combination drug that pairs azidothymidine, also known as AZT, with another antiviral, lamivudine. The combination […]
Synthetic biotechnology company Intrexon — whose website is the descriptive www.dna.com — has raised $100 million that the company will use to expand its genetics technology. With the closing of its series E round of fundraising, Blacksburg, Virginia-based Intrexon has raised more than $259 million. The round was led by new, undisclosed investors. Existing investors […]
Those hoping to pursue a career in nursing can choose between three different levels of the profession. Each level requires specialized coursework and that graduates, of the various specializations, sit for and pass the appropriate licensing exam in their state.
Yesterday’s New York Times (As Physicians’ Jobs Change, So Do Their Politics) highlights the political shift underway within the physician community. While doctors used to be mainly male small businessmen, who were a natural fit with the Republican Party, they’re now much more likely to be female and employed by larger organizations. According to the […]
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
Drug and chemicals analysis company Centice has raised $2.3 million that the company will use to bring its drug identification and verification technology into hospital and law enforcement applications. According to a filing with the U.S. Securities and Exchange Commission, Morrisville, North Carolina-based Centice has raised $2.3 million in a round that targets $4 million. […]
Close observers of the U.S. health reform debate in recent years know that the proceedings have illustrated why Barack Obama can hardly be called a liberal or a progressive. That’s because the president showed no willingness to advocate for most liberals’ top choice for reorganizing the U.S. health system — a Medicare-for-all, single-payer plan in […]
Current medical news from today, including: The "Food Pyramid" gets replaced by the "Food Plate," a shortage of certain drugs is making some hospitals nervous, and doctors reconsider Niaspan.
We have had many family conversations about education reform over the years. Whistleblower readers have seen some of this creeping through some prior posts. It’s an issue that affects every American and deserves the efforts of our most talented and innovative thinkers to elevate the system to a higher orbit. One of the mantras of […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Histogenics Corp. brought in more than $34 million in equity and debt financing after its acquisition of fellow Bay State firm ProChon Biotech Ltd. The two companies merged in an all-stock deal that brings ProChon CEO Patrick O’Donnell into the Histogenics corner office. O’Donnell told MassDevice.com last week that a deal has been in the works […]
Medicine has much to be grateful for to war, but I wish we’d find a peaceful way to make these advances. Here are just a few In 1718, Jean Louis Petit, a French surgeon, invented a screw tourniquet to control bleeding. The screw tourniquet made thigh amputations possible and reduced the risks associated with amputations […]
This week's life science current events from medical bloggers include changes in pharma rep jobs, changes for markers of new innovative medical devices, Stryker is ready for the challenges and alternatives to healthcare venture capital.
Life science current events this week include medical device FDA approvals, a move from University Hospitals Cleveland to Mayo Clinic for Dr. James Levine, and job advice for medical device marketers.
Medical Device industry officials urged Congress to pass a bill that is stalled on Capitol Hill, which they say will benefit the U.S. med tech industry. But U.S. free trade agreements with South Korea, Colombia and Panama won’t get a vote until Congress meets a White House demand to renew the Trade Adjustment Assistance (TAA) […]